🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchSurvodutide (GCG/GLP-1) — anyone have experience? Page 2

Survodutide (GCG/GLP-1) — anyone have experience?

stefan_berlin Sat, Mar 28, 2026 at 5:44 AM 16 replies 838 viewsPage 2 of 4
PeptideChemSF
Senior Member
1,890
9,012
Jan 2024
San Francisco, CA
Mar 28, 2026 at 8:25 PM#6

Adding the numbers, since they settle part of this. For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine. Half the figures circulating in this community trace back to a secondary summary that dropped a qualifier.

Happy to go further on any of that.

Last edited: Mar 29, 2026 at 12:25 AM
49 2steve_okc, dave_SLC, FDA_TrackerJim and 46 others
Reply Quote Save Share Report
Dr.RheumBOS
Member
567
2,345
Apr 2024
Boston, MA
Mar 29, 2026 at 2:15 AM#7

Following on from hans_munich — and this may be the naive question:

Did your prescriber agree with that reading, and if not what was their objection?

50 3wei_SG, cory_ATX, lori_vegas and 47 others
Reply Quote Save Share Report
Dr.PathRoch
Member
456
2,123
Jun 2024
Rochester, MN
Mar 29, 2026 at 8:05 AM#8
PeptideChemSF said:
For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine.

Adding the part of the answer the thread has not reached. There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

1 4WendyG_ATL
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
stefan_berlin
Member
234
1,123
Oct 2024
Berlin, DE
Mar 29, 2026 at 1:55 PM#9

Reporting back.

Following up because I said I would. I changed one thing, left everything else alone, and waited the full interval before looking. It resolved, and I cannot prove which half of that did it.

2 5TirzTom, TrialTracker_MD
Reply Quote Save Share Report
KetoKyle
Member
678
3,456
Jul 2024
Utah
Mar 30, 2026 at 5:55 PM#10
Dr.PathRoch said:
There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

Correct, and worth adding that it is reversible. Nothing being described here is a one-way door, which changes how cautious it is reasonable to be.

50 0JakeBK_lifts, DerekSJ_a1c, paige_pharma and 47 others
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register